GDF15 and lung carcinoma: Our ROC results showed that serum MIC-1 was insufficient to differentiate patients with early-stage lung cancer from benign lung tumors, although AUC value was found to approximate that of Cyfra21-1 and to be superior to NSE, CA125, CEA and SCC.